B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

DNA2

MOLECULAR TARGET

DNA replication helicase/nuclease 2

UniProt: P51530NCBI Gene: 17631 compounds

DNA2 (DNA replication helicase/nuclease 2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting DNA2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Uridine Triphosphate Uridine 5'-(tetrahydrogen triphosphate).1.102

About DNA2 as a Drug Target

DNA2 (DNA replication helicase/nuclease 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented DNA2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

DNA2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.